Skip to content
OpenCapital
Get started

Aurinia Pharmaceuticals AUPH Q3 2025 earnings

Reported November 4, 2025 · Before market open

Revenue$73.5MMiss by $1.2M
EPS$0.23Beat by $0.07
Revenue estimate$74.7M
EPS estimate$0.16

Next report

Jul 30, 2026 (Tomorrow)
Revenue estimate$80.4M
EPS estimate$0.19

Financials

Q3 2025

Income statement

See full
Revenue$73.5M+8.4%
Gross profit$65.3M+5.8%
Operating income$29.7M+153%
Net income$31.6M+120%
EPS (diluted)$0.23+130%

Balance sheet

See full
Cash & equivalents$73.2M+97.1%
Total debt$94.5M-8.0%
Total equity$365.8M-5.7%
Total assets$527.5M-4.0%

Cash flow

See full
Operating cash flow$44.4M+161%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$1.45B+38.7%
Enterprise value$1.48B+32.5%
P/E18.7×—
P/S5.5×+0.7×

Profitability

See full
Gross margin88.9%+1.7pp
Operating margin26.3%+19.4pp
Net margin29.3%+23.3pp

Returns & leverage

See full
Return on equity20.7%+16.9pp
Debt / equity0.3×0.0×
Current ratio5.8×+0.2×

Segments

By product

See full
License, collaboration and royalty revenue$2.8M—

Versus estimates

Revenue

Q1 2026$77.7MBeat by $726.3KQ4 2025$77.1MBeat by $2.4M
Q3 2025$73.5MMiss by $1.2M
Q2 2025$70.0MBeat by $2.3MQ1 2025$62.5MMiss by $2.2MQ4 2024$59.9MMiss by $2.0M

Diluted EPS

Q1 2026$0.25Beat by $0.07Q4 2025$0.26Beat by $0.05
Q3 2025$0.23Beat by $0.07
Q2 2025$0.16Miss by $0.01Q1 2025$0.16Beat by $0.08Q4 2024$0.09Beat by $0.06

Ask the moment Aurinia Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Aurinia Pharmaceuticals report Q3 2025 earnings?
Aurinia Pharmaceuticals (AUPH) reported Q3 2025 earnings on November 4, 2025 before market open.
What were Aurinia Pharmaceuticals's Q3 2025 revenue and EPS?
Aurinia Pharmaceuticals reported revenue of $73.5M and eps of $0.23 for Q3 2025.
Did Aurinia Pharmaceuticals beat estimates in Q3 2025?
Revenue missed the consensus estimate of $74.7M by $1.2M. EPS beat the consensus estimate of $0.16 by $0.07.
How did Aurinia Pharmaceuticals's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 8.4% from $67.8M a year earlier and eps grew 130.0% from $0.10.
Where can I find Aurinia Pharmaceuticals's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001600620-25-000108) and the 10-Q periodic report (0001600620-25-000106) directly on SEC EDGAR. The filing index links above go to sec.gov.